These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 11926745)

  • 21. Immunocompromised hosts: perspectives in the treatment and prophylaxis of cytomegalovirus disease in solid-organ transplant recipients.
    Torres-Madriz G; Boucher HW
    Clin Infect Dis; 2008 Sep; 47(5):702-11. PubMed ID: 18652557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel Cytomegalovirus UL54 DNA Polymerase Gene Mutations Selected In Vitro That Confer Brincidofovir Resistance.
    Chou S; Ercolani RJ; Lanier ER
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3845-8. PubMed ID: 27044553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclopropavir susceptibility of cytomegalovirus DNA polymerase mutants selected after antiviral drug exposure.
    Chou S; Marousek G; Bowlin TL
    Antimicrob Agents Chemother; 2012 Jan; 56(1):197-201. PubMed ID: 21968367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cidofovir for cytomegalovirus-preemptive therapy in stem cell transplant recipients.
    Kiehl MG; Basara N
    Blood; 2001 Sep; 98(5):1626; author reply 1628. PubMed ID: 11547768
    [No Abstract]   [Full Text] [Related]  

  • 25. Alkoxyalkyl esters of cidofovir and cyclic cidofovir exhibit multiple-log enhancement of antiviral activity against cytomegalovirus and herpesvirus replication in vitro.
    Beadle JR; Hartline C; Aldern KA; Rodriguez N; Harden E; Kern ER; Hostetler KY
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2381-6. PubMed ID: 12121908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved detection of emerging drug-resistant mutant cytomegalovirus subpopulations by deep sequencing.
    Chou S; Ercolani RJ; Sahoo MK; Lefterova MI; Strasfeld LM; Pinsky BA
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4697-702. PubMed ID: 24890586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Recent advances in antiviral drugs--antiviral agents to HCMV, HHV-6, and HHV-7].
    Takahashi K
    Nihon Rinsho; 1998 Jan; 56(1):140-4. PubMed ID: 9465679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiviral drug resistance of human cytomegalovirus.
    Lurain NS; Chou S
    Clin Microbiol Rev; 2010 Oct; 23(4):689-712. PubMed ID: 20930070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accelerated evolution of maribavir resistance in a cytomegalovirus exonuclease domain II mutant.
    Chou S; Marousek GI
    J Virol; 2008 Jan; 82(1):246-53. PubMed ID: 17942550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic analysis of a clinical isolate of human cytomegalovirus exhibiting resistance against both ganciclovir and cidofovir.
    Harada K; Eizuru Y; Isashiki Y; Ihara S; Minamishima Y
    Arch Virol; 1997; 142(2):215-25. PubMed ID: 9125039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic options for resistant cytomegalovirus retinitis.
    Kuppermann BD
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997; 14 Suppl 1():S13-21. PubMed ID: 9058613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytomegalovirus mutants resistant to ganciclovir and cidofovir differ in susceptibilities to synguanol and its 6-ether and 6-thioether derivatives.
    Chou S; Komazin-Meredith G; Williams JD; Bowlin TL
    Antimicrob Agents Chemother; 2014; 58(3):1809-12. PubMed ID: 24379208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options.
    Reusser P
    J Hosp Infect; 1996 Aug; 33(4):235-48. PubMed ID: 8864937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of cytomegalovirus DNA polymerase (UL54) mutations in solid organ transplant patients receiving valganciclovir or ganciclovir prophylaxis.
    Boivin G; Goyette N; Gilbert C; Covington E
    J Med Virol; 2005 Nov; 77(3):425-9. PubMed ID: 16173018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergy of bovine lactoferrin with the anti-cytomegalovirus drug cidofovir in vitro.
    van der Strate BW; De Boer FM; Bakker HI; Meijer DK; Molema G; Harmsen MC
    Antiviral Res; 2003 Apr; 58(2):159-65. PubMed ID: 12742576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical failure of CMV retinitis with intravitreal cidofovir is associated with antiviral resistance.
    Smith IL; Taskintuna I; Rahhal FM; Powell HC; Ai E; Mueller AJ; Spector SA; Freeman WR
    Arch Ophthalmol; 1998 Feb; 116(2):178-85. PubMed ID: 9488269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New inhibitors of cytomegalovirus replication: in vitro evaluation, mechanism of action, and in vivo activity.
    Neyts J; De Clercq E
    Verh K Acad Geneeskd Belg; 1994; 56(6):561-92. PubMed ID: 7892749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A point mutation in the human cytomegalovirus DNA polymerase gene selected in vitro by cidofovir confers a slow replication phenotype in cell culture.
    Cihlar T; Fuller MD; Mulato AS; Cherrington JM
    Virology; 1998 Sep; 248(2):382-93. PubMed ID: 9721246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multidrug resistance conferred by novel DNA polymerase mutations in human cytomegalovirus isolates.
    Scott GM; Weinberg A; Rawlinson WD; Chou S
    Antimicrob Agents Chemother; 2007 Jan; 51(1):89-94. PubMed ID: 17043128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir.
    Boivin G; Goyette N; Rollag H; Jardine AG; Pescovitz MD; Asberg A; Ives J; Hartmann A; Humar A
    Antivir Ther; 2009; 14(5):697-704. PubMed ID: 19704173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.